Skip to main content
KAPA logo

KAPA · Kairos Pharma, LTD.

Track KAPA — free
$0.24 0.00 (-1.62%) At close · Aug 28
Market Cap
$5.62M
Shares
23.70M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 14
Total Value: $9,254
Total Shares: 967,960

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 14 13F filers
Top Holder
100.0%
Sep 2024 → Jun 2026 · range 0.0% – 100.0%
of institutional value
Top 5
100.0%
Sep 2024 → Jun 2026 · range 0.0% – 100.0%
of institutional value
Top 10
100.0%
Sep 2024 → Jun 2026 · range 0.0% – 100.0%
of institutional value
HHI
10,000
Sep 2024 → Jun 2026 · range 0 – 10,000
Highly concentrated

Quarterly Activity

vs Mar 31, 2026
New
7
Increased
0
Decreased
2
Sold Out
4
Unchanged
5
Holder count: +3
Institutional value:
Shares held: +61.0%

Top Buyers

vs Mar 31, 2026
No qualifying movers this quarter.

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1962011 CUSIP 48301N104 13F (30d) 14 filings 14 filers Visit website Investor relations